Published : Apr-2019
No. of Pages : 48
1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Nebulizers Overview
3 Products under Development
3.1 Nebulizers - Pipeline Products by Stage of Development
3.2 Nebulizers - Pipeline Products by Segment
3.3 Nebulizers - Pipeline Products by Territory
3.4 Nebulizers - Pipeline Products by Regulatory Path
3.5 Nebulizers - Pipeline Products by Estimated Approval Date
3.6 Nebulizers - Ongoing Clinical Trials
4 Nebulizers - Pipeline Products under Development by Companies
4.1 Nebulizers Companies - Pipeline Products by Stage of Development
4.2 Nebulizers - Pipeline Products by Stage of Development
5 Nebulizers Companies and Product Overview
5.1 Ablynx NV Company Overview
5.2 Aeon Research & Technology Company Overview
5.3 AFT Pharmaceuticals Ltd Company Overview
5.4 Aura Medical Company Overview
5.5 Baby's Breath Ltd. Company Overview
5.6 Creare LLC Company Overview
5.7 DesignWise Medical Inc (Inactive) Company Overview
5.8 Marquette University Company Overview
5.9 Parion Sciences Inc Company Overview
5.10 SolAeroMed Inc Company Overview
5.11 Stirling Pharma Inc Company Overview
5.12 University of California San Diego Company Overview
5.13 University of Texas Medical Branch at Galveston Company Overview
5.14 Verona Pharma Plc Company Overview
5.15 Vincent Medical Holdings Ltd Company Overview
6 Nebulizers- Recent Developments
6.1 Jul 16, 2018: Vectura Appoints Paul Fry as Chief Financial Officer and Executive Director
6.2 Jun 22, 2018: Owens & Minor Names Timothy P. Connolly as EVP, Operations & Supply Chain-Global Solutions
6.3 Jun 19, 2018: Cardinal Health Foundation Awards Over $3 Million to More Than 70 Nonprofit Organizations to Fight the Opioid Epidemic across Appalachia
6.4 Jun 04, 2018: Owens & Minor Appoints Interim Chief Financial Officer, as well as a Chief Accounting Officer
6.5 Jun 01, 2018: Vectura Group Appoints Anne Whitaker As Non-Executive Director
6.6 May 31, 2018: Copley Scientific releases new accessories for testing nebulisers with facemasks
6.7 May 29, 2018: Savara Provides Update on Case Reports of Inhaled Granulocyte-Macrophage Colony Stimulating Factor for the Treatment of Nontuberculous Mycobacteria Infection
6.8 May 24, 2018: OMRON Healthcare invests R$ 60 million to build a new plant in Jundia
6.9 May 14, 2018: Henry Ford Neurosurgeon and Epilepsy Expert Named President of National Pain Management Advocacy Group
6.10 May 11, 2018: Teleflex: Reaffirms 2018 Guidance and Provides 3-Year Financial Goals and Objectives
6.11 May 03, 2018: Cardinal Health Announces Third-quarter Results for Fiscal Year 2018
6.12 May 03, 2018: Teleflex Reports First Quarter 2018 Results
6.13 Apr 25, 2018: Boehringer Ingelheim has a very successful 2017 financial year
6.14 Apr 20, 2018: Vectura Announces Senior Management Change
6.15 Apr 20, 2018: Vectura Group: Directorate Change - Chief Financial Officer
7 Appendix
7.1 Methodology
7.2 About GlobalData
7.3 Contact Us
7.4 Disclaimer
1.1 List of Tables
Table 1: Nebulizers - Pipeline Products by Stage of Development
Table 2: Nebulizers - Pipeline Products by Segment
Table 3: Nebulizers - Pipeline Products by Territory
Table 4: Nebulizers - Pipeline Products by Regulatory Path
Table 5: Nebulizers - Pipeline Products by Estimated Approval Date
Table 6: Nebulizers - Ongoing Clinical Trials
Table 7: Nebulizers Companies - Pipeline Products by Stage of Development
Table 8: Nebulizers - Pipeline Products by Stage of Development
Table 9: Ablynx NV Pipeline Products & Ongoing Clinical Trials Overview
Table 10: Customised Infant Inhalation Device - Product Status
Table 11: Customised Infant Inhalation Device - Product Description
Table 12: Aeon Research & Technology Pipeline Products & Ongoing Clinical Trials Overview
Table 13: LYNX Nebulizer - Product Status
Table 14: LYNX Nebulizer - Product Description
Table 15: AFT Pharmaceuticals Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 16: NasoSURF - Product Status
Table 17: NasoSURF - Product Description
Table 18: AFT Pharmaceuticals Ltd - Ongoing Clinical Trials Overview
Table 19: NasoSURF - A Single Center, Randomized, Controlled, Four Way Cross-over Clinical Study Investigating the Deposition of Aerosol Generated by the Nasal Mesh Nebulizer (NMN) Prototype into the Nasal Cavity Using Radio-labelled Saline at Different Pulse Frequency in Healthy Volunteers
Table 20: Aura Medical Pipeline Products & Ongoing Clinical Trials Overview
Table 21: Nebican - Product Status
Table 22: Nebican - Product Description
Table 23: Baby's Breath Ltd. Pipeline Products & Ongoing Clinical Trials Overview
Table 24: WiseAir - Product Status
Table 25: WiseAir - Product Description
Table 26: Creare LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 27: DDC-Based Nebulizer - Product Status
Table 28: DDC-Based Nebulizer - Product Description
Table 29: DesignWise Medical Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 30: Self-Contained Nebulizer System - Product Status
Table 31: Self-Contained Nebulizer System - Product Description
Table 32: Marquette University Pipeline Products & Ongoing Clinical Trials Overview
Table 33: Human Powered Nebulizer - Product Status
Table 34: Human Powered Nebulizer - Product Description
Table 35: Parion Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 36: tPAD Device - Product Status
Table 37: tPAD Device - Product Description
Table 38: SolAeroMed Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 39: S1226 Neublizer System - Product Status
Table 40: S1226 Neublizer System - Product Description
Table 41: Stirling Pharma Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 42: High Density Aerosol Drug Delivery Device - Product Status
Table 43: High Density Aerosol Drug Delivery Device - Product Description
Table 44: University of California San Diego Pipeline Products & Ongoing Clinical Trials Overview
Table 45: Nebulizer - Product Status
Table 46: Nebulizer - Product Description
Table 47: University of Texas Medical Branch at Galveston Pipeline Products & Ongoing Clinical Trials Overview
Table 48: Pulse Drug Nebulization System - Product Status
Table 49: Pulse Drug Nebulization System - Product Description
Table 50: Verona Pharma Plc Pipeline Products & Ongoing Clinical Trials Overview
Table 51: RPL554 Nebulizer - Product Status
Table 52: RPL554 Nebulizer - Product Description
Table 53: Vincent Medical Holdings Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 54: Home Use Ultrasonic Nebulizer - Product Status
Table 55: Home Use Ultrasonic Nebulizer - Product Description
Table 56: Glossary
1.2 List of Figures
Figure 1: Nebulizers - Pipeline Products by Stage of Development
Figure 2: Nebulizers - Pipeline Products by Segment
Figure 3: Nebulizers - Pipeline Products by Territory
Figure 4: Nebulizers - Pipeline Products by Regulatory Path
Figure 5: Nebulizers - Pipeline Products by Estimated Approval Date
Figure 6: Nebulizers - Ongoing Clinical Trials